An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis

Marion Zillhardt, James G. Christensen, Ernst Lengyel

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis'. Together they form a unique fingerprint.

Medicine & Life Sciences